A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy. [PDF]
Dal Negro RW, Povero M.
europepmc +1 more source
Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™). [PDF]
Pasteka R +4 more
europepmc +1 more source
The complexity of COPD and medication adherence [PDF]
• Patients with COPD may also suffer from other conditions, such as anxiety disorders, cardiac disease or diabetes. • Tobacco smoking is recognised as the most common cause of COPD, so smoking cessation may be one way of successfully managing the ...
Dury, Rona
core
Considerations for managing chronic obstructive pulmonary disease in the elderly
George E Taffet,1 James F Donohue,2 Pablo R Altman31Geriatrics Section, Geriatrics and Cardiovascular Sciences, Baylor College of Medicine, The Methodist Hospital, Houston, TX, 2Pulmonary Diseases and Critical Care Medicine, University of North Carolina,
Taffet GE, Donohue JF, Altman PR
doaj
Asthma and chronic obstructive pulmonary disease (COPD) continue to pose significant global health burdens, with optimal inhalation therapy being central to effective disease control.
Selvakumar Muruganantham +1 more
doaj +1 more source
Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents. [PDF]
Dal Negro RW, Turco P, Povero M.
europepmc +1 more source
Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam. [PDF]
Party P +4 more
europepmc +1 more source
Effects of dose loading conditions and device geometry on the transport and aerosolization in dry powder inhalers: A simulation study. [PDF]
Sulaiman M, Liu X, Sundaresan S.
europepmc +1 more source
Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications. [PDF]
Zheng Z, Leung SSY, Gupta R.
europepmc +1 more source
Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension. [PDF]
Faria-Urbina M +4 more
europepmc +1 more source

